Aclaris Therapeutics, Inc. · NASDAQ:ACRS

BlackRock, Inc. reported a 6.20% stake in Aclaris Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Jan 21, 2026

BlackRock, Inc. reported a 6.20% stake in Aclaris Therapeutics, Inc., 6,700,629 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G/A).

Stake
6.20%
Shares
6,700,629
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.6.20%6,700,629

Source

View original at SEC

Related